Pediatric Hematology · Autosomal Recessive Congenital Sideroblastic Anemia

Long-Term Monitoring: Iron Overload and Health

At a Glance

Children with autosomal recessive sideroblastic anemia need individualized long-term monitoring because iron can build up even without transfusions. Ferritin trends, growth checks, and liver and heart MRI help detect organ effects early, while families should follow written emergency plans.

Managing Autosomal Recessive Congenital Sideroblastic Anemia (AR-CSA) involves a lifetime of careful monitoring. Because iron can build up in the body even before a child starts receiving transfusions, keeping a close eye on “iron trends” is the most important way to protect your child’s organs ^[1]^[2].

The Danger of Iron Overload

In a child with AR-CSA, iron can accumulate slowly over time. Because the body cannot use the iron to make healthy red blood cells effectively, the extra iron is stored in places it doesn’t belong ^[1].

The Liver: This is usually the first place iron is stored. Over time, too much iron can lead to scarring (fibrosis) ^[3].
The Heart: Iron buildup in the heart is particularly serious because it can weaken the heart muscle, leading to cardiomyopathy or heart failure ^[4]^[5].
The Endocrine System: Iron often deposits in the glands that produce hormones. This can cause issues with growth, delayed puberty, or problems regulating blood sugar (diabetes) ^[6]^[7].

Your Child’s Surveillance Schedule

Because every child’s iron levels rise at a different rate, there is no single “correct” schedule. The intervals below are examples, but your team must individualize them based on transfusions, age, and local protocols ^[3]:

Test	Frequency	What it Measures
Serum Ferritin	Every 1–3 months (example)	An indirect blood marker of iron stores. Note: Ferritin fluctuates with inflammation and liver injury; it must be interpreted alongside other data ^[8]^[9].
Growth Tracking	Every visit	Plotting height and weight to catch growth curve changes early ^[10].
Liver/Cardiac MRI (T2)*	Individualized (e.g., 1-2 yrs)	A specialized MRI that estimates tissue-specific iron in the heart and liver ^[3]^[4].
Glucose/Thyroid/Medications	Annually or as directed	Blood tests for endocrine function and drug-specific monitoring (e.g., renal/liver/vision tests for chelators) ^[6].

When to Seek Emergency Care

While most days with AR-CSA are manageable, there are specific “red flags” that require immediate medical attention. If you notice these symptoms, do not wait for a specialist appointment; seek urgent emergency care or contact your hematology team immediately as directed.

Urgent Cardiac Symptoms:

Difficulty Breathing: Any new shortness of breath, especially when resting or during light play, can be a sign of heart strain or fluid around the heart (pericardial effusion) ^[11]^[12]. Proceed to emergency assessment.
Chest Pain or Fainting: Any episode of fainting (syncope), blue lips, or complaints of chest pain requires urgent ER evaluation ^[5].

Hematologic Symptoms:

Extreme Paleness or Lethargy: A sudden drop in energy, reduced responsiveness, or very pale skin/lips can signal an “anemia crisis” where hemoglobin levels have dropped dangerously low ^[8]^[13].
Unexplained Bleeding or Bruising: Contact the team for any new, severe, persistent, or unexplained bruising or bleeding.

Specifically for TRNT1 (SIFD) and Post-HSCT:

Fever (100.4°F / 38°C or higher): Because SIFD involves a variable weakened immune system, a fever always requires following your child’s individualized written fever plan. This plan will direct you on when to call the after-hours clinic and when to go to the emergency room ^[14]^[15].
Unexplained Shaking or Sweating: This may be a sign of low blood sugar (hypoglycemia), which has been reported in some children with TRNT1 ^[6]. Check glucose if directed, and seek urgent assessment.

Navigating the Psychological Toll

Living from one scan to the next can create a unique kind of stress often called “scan anxiety.” It is normal to feel a spike in fear or irritability in the weeks leading up to an MRI or a major blood draw ^[16]^[17].

Preparation is Key: For younger children, “child-life specialists” can help prepare them for the MRI using play or “mock” scanners to reduce the need for sedation ^[18].
Seek Support: Rare disease parents often face higher rates of isolation and stress. Connecting with a therapist or a specialized support group can provide a safe space to process these feelings ^[19]^[20].

Common questions in this guide

Why does a child with AR-CSA need long-term iron monitoring?

Iron can accumulate in the body in autosomal recessive congenital sideroblastic anemia, sometimes even before transfusions begin. Over time, excess iron may affect the liver, heart, and hormone-producing glands, so regular monitoring helps the care team respond early.

What does my child’s ferritin trend tell the care team?

Ferritin is a blood marker that provides an indirect estimate of stored iron. It can also change with inflammation or liver injury, so doctors interpret the trend alongside other tests rather than relying on one result.

When might my child need a liver or heart T2* MRI?

The timing of a T2* MRI depends on your child’s age, transfusion history, iron levels, and local care protocols. This specialized MRI estimates how much iron is stored in the liver and heart, and the hematology team should individualize the schedule.

Which symptoms mean my child needs urgent medical care?

New shortness of breath, chest pain, fainting, blue lips, sudden extreme paleness, or unusual lethargy can signal a serious heart or anemia-related problem. Seek emergency assessment or contact the hematology team immediately as directed for these symptoms.

What should families do if a child with TRNT1-related SIFD develops a fever?

A temperature of 100.4°F (38°C) or higher requires following the child’s individualized written fever plan. Because SIFD can involve a weakened immune system, the plan should explain when to call the after-hours clinic and when to go to the emergency room.

How can we reduce a child’s anxiety about repeated MRI scans?

Child-life specialists can use play, preparation, and mock scanners to make MRI procedures more familiar and may reduce the need for sedation. A therapist or rare-disease support group can also help children and caregivers manage ongoing scan-related stress.

Get notified when new evidence is published on Autosomal recessive sideroblastic anemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (20)

1
Pathophysiology and classification of iron overload diseases; update 2018.
Brissot P, Troadec MB, Loréal O, Brissot E
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.
PMID: 30173950
2
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119
3
Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.
Le Rouzic MA, Fouquet C, Leblanc T, et al.
Blood cells, molecules & diseases 2017; (66()):11-18 doi:10.1016/j.bcmd.2017.07.003.
PMID: 28772256
4
Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.
Kirk P, Sheppard M, Carpenter JP, et al.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2017; (19(1)):36 doi:10.1186/s12968-017-0349-3.
PMID: 28343449
5
Atypical SIFD with novel TRNT1 mutations: a case study on the pathogenesis of B-cell deficiency.
Kumaki E, Tanaka K, Imai K, et al.
International journal of hematology 2019; (109(4)):382-389 doi:10.1007/s12185-019-02614-0.
PMID: 30758723
6
A phenotypic expansion of TRNT1 associated sideroblastic anemia with immunodeficiency, fevers, and developmental delay.
Odom J, Amin H, Gijavanekar C, et al.
American journal of medical genetics. Part A 2022; (188(1)):259-268 doi:10.1002/ajmg.a.62482.
PMID: 34510712
7
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.
Fouquet C, Le Rouzic MA, Leblanc T, et al.
British journal of haematology 2019; (187(4)):530-542 doi:10.1111/bjh.16100.
PMID: 31338833
8
A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.
Cai J, Liu T, Huang Y, et al.
Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.
PMID: 39281190
9
A case report of congenital sideroblastic anemia caused by a novel ALAS2 mutation in conjunction with thalassemia.
Chen ZX, Yang LY, Wang LT, et al.
Annals of hematology 2026; (105(5)).
PMID: 41961321
10
Prognostic Factors for Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fevers, and Developmental Delay Due to TRNT1 Gene Mutations: A Case Report and Systematic Review.
Su TH, Lee NC, Wang LC, et al.
Journal of clinical immunology 2026; (46(1)).
PMID: 41795040
11
COVID-19 associated respiratory failure complicating a pericardial effusion in a patient with sideroblastic anemia.
Sayad E, Hammoud M, Khreis D, et al.
Respiratory medicine case reports 2021; (34()):101543 doi:10.1016/j.rmcr.2021.101543.
PMID: 34777989
12
Graft failure after reduced-intensity stem cell transplantation for congenital sideroblastic anemia.
Imataki O, Uchida S, Uemura M, Kadowaki N
Pediatric hematology and oncology 2019; (36(1)):46-51 doi:10.1080/08880018.2019.1578844.
PMID: 30912988
13
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Abu-Zeinah G, DeSancho MT
Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.
PMID: 33061728
14
Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.
Giannelou A, Wang H, Zhou Q, et al.
Annals of the rheumatic diseases 2018; (77(4)):612-619 doi:10.1136/annrheumdis-2017-212401.
PMID: 29358286
15
Expanding the spectrum of Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fever and Developmental Delay (SIFD) syndrome: a case report with new clinical insights and novel genetic variant.
Delle Cave F, Taietti I, Agostini A, et al.
Frontiers in immunology 2026; (17()):1876025 doi:10.3389/fimmu.2026.1876025.
PMID: 42688123
16
Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases.
Bogart K, Hemmesch A, Barnes E, et al.
Orphanet journal of rare diseases 2022; (17(1)):196 doi:10.1186/s13023-022-02343-4.
PMID: 35549731
17
Children with a rare congenital genetic disorder: a systematic review of parent experiences.
von der Lippe C, Neteland I, Feragen KB
Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.
PMID: 36253830
18
[Measures for optimal access to psychosocial care of children with rare diseases and their families].
Witt S, Kristensen K, Wiegand-Grefe S, Quitmann J
Innere Medizin (Heidelberg, Germany) 2023; (64(5)):494-499 doi:10.1007/s00108-023-01496-z.
PMID: 36988654
19
Quality of life of Brazilian families who have children with Rubinstein-Taybi syndrome: An exploratory cross-sectional study.
Vale AR, de Avó LRDS, Pilotto RF, et al.
American journal of medical genetics. Part A 2022; (188(11)):3294-3305 doi:10.1002/ajmg.a.62914.
PMID: 35913016
20
Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.
Delisle VC, Gumuchian ST, Rice DB, et al.
The patient 2017; (10(3)):283-293 doi:10.1007/s40271-016-0213-9.
PMID: 28004275

This page is for informational purposes only and does not constitute medical advice. It cannot replace your child’s individualized monitoring, fever, or emergency plan from their hematology team.